Australian biotech company Microbio has been awarded an Australian Government Advanced Manufacturing Growth Centre (AMGC) co-investment of $407,000 to enable the company to establish sovereign manufacturing capabilities in Australia for a test to identify potential biological threats.
The company will manufacture specific oligonucleotides, a unique component used in its product suite, which includes InfectID-BSI, InfectID-COVID and InfectID-SSBA: its patented one-tube, seven-pathogen test to rapidly detect Security Sensitive Biological Agents (SSBAs).
Read more in the Media Release
Microbio is pleased to announce it has appointed a distributor in India for its range of COVID-19 tests.
The appointment of Indian firm, BioGTech, follows the approval of Microbio’s COVID-19 tests by the Indian Council of Medical Research (ICMR), and validation testing by Rajiv Gandhi Centre for Biotechnology (RGCB). The first deliveries to India are expected to be made in coming weeks.
Find out more in the media release: 211209_Microbio_prepares_for_first_deliveries_in_India
Dr Flavia Huygens has been honoured with one of DMTC’s 2020 Excellence Awards. Dr Huygens received the Project Leadership Award: “In recognition of exemplary professional conduct in support of DMTC’s objectives.”
The awards evening was held during the DMTC Annual Conference, 11-12 March 2020 in Canberra. The conference highlights the projects building defence and national security capabilities through collaboration with industry.
Dr Huygens was also invited to present at the conference to share progress on a project to develop a highly sensitive and specific pathogen identification diagnostic test. This project is a collaboration between DMTC Ltd, Microbio and Queensland University of Technology.